Human embryonic stem cells (hESCs) hold great value for future clinical applications. However, standard culture conditions maintain hESCs in a primed state, which bears heterogeneity in pluripotency and a tendency for spontaneous differentiation. To counter these drawbacks, primed hESCs have been converted to a naive state, but this has restricted the efficiency of existing directed differentiation protocols. In mouse, WNT inhibition by inhibitor of WNT production-2, together with a higher dose of fibroblast growth factor 2 (12 ng/mL) in DMEM/F12 basal medium (DhiFI), markedly improved derivation and maintenance of primed mouse epiblast stem cells. In this study, we show that DhiFI conditions similarly improved primed hESC traits, such as conferring a primed transcriptional signature with high levels of pluripotency markers and reduced levels of differentiation markers. When triggered to differentiate to neuronal and cardiac lineages, DhiFI hESCs and isogenic primed hESCs progressed similarly. Moreover, DhiFI conditions supported the derivation of hESC lines from a post-inner cell mass intermediate (PICMI). DhiFI-derived hESCs showed less spontaneous differentiation and expressed significantly lower levels of lineage-specific markers, compared to primed-derived lines from the same PICMI. Overall, DhiFI hESCs retained advantages of both primed and naive pluripotency and may ultimately represent a more favorable starting point for differentiation toward clinically desired cell types.
Get full access to this article
View all access options for this article.
References
1.
Van der JeughtM, O'LearyT, DuggalG, De SutterP, Chuva de Sousa LopesS and HeindryckxB. (2015). The post-inner cell mass intermediate: implications for stem cell biology and assisted reproductive technology. Hum Reprod Update, 21:616–626.
2.
ThomsonJA, Itskovitz-EldorJ, ShapiroSS, WaknitzMA, SwiergielJJ, MarshallVS and JonesJM. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282:1145–1147.
3.
ReubinoffBE, PeraMF, FongC-Y, TrounsonA and BongsoA. (2000). Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol, 18:399–404.
4.
AmitM, CarpenterMK, InokumaMS, ChiuC-P, HarrisCP, WaknitzMA, Itskovitz-EldorJ and ThomsonJA. (2000). Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol, 227:271–278.
5.
MarksH, KalkanT, MenafraR, DenissovS, JonesK, HofemeisterH, NicholsJ, KranzA, StewartAF, SmithA and StunnenbergHG. (2012). The transcriptional and epigenomic foundations of ground state pluripotency. Cell, 149:590–604.
6.
SingerZS, YongJ, TischlerJ, HackettJA, AltinokA, SuraniMA, CaiL and ElowitzMB. (2014). Dynamic heterogeneity and DNA methylation in embryonic stem cells. Mol Cell, 55:319–331.
7.
KalkanT, OlovaN, RoodeM, MulasC, LeeHJ, NettI, MarksH, WalkerR, StunnenbergHG, et al. (2017). Tracking the embryonic stem cell transition from ground state pluripotency. Development, 144:1221–1234.
8.
MousavinejadM, AndrewsPW and ShorakiEK. (2016). Current biosafety considerations in stem cell therapy. Cell J, 18:281–287.
9.
O'learyT, HeindryckxB, LiermanS, Van BruggenD, GoemanJJ, VandewoestyneM, DeforceD, de Sousa LopesSMC and De SutterP. (2012). Tracking the progression of the human inner cell mass during embryonic stem cell derivation. Nat Biotechnol, 30:278–282.
10.
O'LearyT, HeindryckxB, LiermanS, Van der JeughtM, DuggalG, De SutterP and Chuva de Sousa LopesSM. (2013). Derivation of human embryonic stem cells using a post-inner cell mass intermediate. Nat Protoc, 8:254–264.
11.
BronsIGM, SmithersLE, TrotterMWB, Rugg-GunnP, SunB, Chuva de Sousa LopesSM, HowlettSK, ClarksonA, Ahrlund-RichterL, PedersenRA and VallierL. (2007). Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature, 448:191–195.
12.
TesarPJ, ChenowethJG, BrookFA, DaviesTJ, EvansEP, MackDL, GardnerRL and McKayRDG. (2007). New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature, 448:196–199.
13.
NicholsJ and SmithA. (2009). Naive and primed pluripotent states. Cell Stem Cell, 4:487–492.
14.
OsafuneK, CaronL, BorowiakM, MartinezRJ, Fitz-GeraldCS, SatoY, CowanCA, ChienKR and MeltonDA. (2008). Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol, 26:313–315.
15.
BockC, KiskinisE, VerstappenG, GuH, BoultingG, SmithZD, ZillerM, CroftGF, AmorosoMW, et al. (2011). Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell, 144:439–452.
16.
WareCB. (2017). Concise review: lessons from naive human pluripotent cells. Stem Cells, 35:35–41.
17.
MorganiS, NicholsJ and HadjantonakisA-K. (2017). The many faces of pluripotency: in vitro adaptations of a continuum of in vivo states. BMC Dev Biol, 17:7.
18.
LeeJ-H, LarondeS, CollinsTJ, ShapovalovaZ, TanasijevicB, McNicolJD, Fiebig-ComynA, BenoitYD, LeeJB, MitchellRR and BhatiaM. (2017). Lineage-specific differentiation is influenced by state of human pluripotency. Cell Rep, 19:20–35.
19.
DavidsonKC, AdamsAM, GoodsonJM, McDonaldCE, PotterJC, BerndtJD, BiecheleTL, TaylorRJ and MoonRT. (2012). WNT/β-catenin signaling promotes differentiation, not self-renewal, of human embryonic stem cells and is repressed by OCT4. Proc Natl Acad Sci U S A, 109:4485–4490.
20.
KurekD, NeaguA, TastemelM, TüysüzN, LehmannJ, van de WerkenHJG, PhilipsenS, van der LindenR, MaasA, et al. (2015). Endogenous WNT signals mediate BMP-induced and spontaneous differentiation of epiblast stem cells and human embryonic stem cells. Stem Cell Reports, 4:114–128.
21.
BlauwkampTA, NigamS, ArdehaliR, WeissmanIL and NusseR. (2012). Endogenous WNT signalling in human embryonic stem cells generates an equilibrium of distinct lineage-specified progenitors. Nat Commun, 3:1070.
22.
SumiT, TsuneyoshiN, NakatsujiN and SuemoriH. (2008). Defining early lineage specification of human embryonic stem cells by the orchestrated balance of canonical WNT/β-catenin, Activin/Nodal and BMP signaling. Development, 135:2969–2979.
23.
TsakiridisA, HuangY, BlinG, SkylakiS, WymeerschF, OsornoR, EconomouC, KaragianniE, ZhaoS, LowellS and WilsonV. (2014). Distinct WNT-driven primitive streak-like populations reflect in vivo lineage precursors. Development, 141:1209–1221.
24.
SumiT, OkiS, KitajimaK and MenoC. (2013). Epiblast ground state is controlled by canonical WNT/β-catenin signaling in the postimplantation mouse embryo and epiblast stem cells. PLoS One, 8:e63378.
25.
OgawaK, NishinakamuraR, IwamatsuY, ShimosatoD and NiwaH. (2006). Synergistic action of WNT and LIF in maintaining pluripotency of mouse ES cells. Biochem Biophys Res Commun, 343:159–166.
26.
ten BergeD, KurekD, BlauwkampT, KooleW, MaasA, ErogluE, SiuRK and NusseR. (2011). Embryonic stem cells require WNT proteins to prevent differentiation to epiblast stem cells. Nat Cell Biol, 13:1070–1075.
27.
XuZ, RobitailleAM, BerndtJD, DavidsonKC, FischerKA, MathieuJ, PotterJC, Ruohola-BakerH and MoonRT. (2016). WNT/β-catenin signaling promotes self-renewal and inhibits the primed state transition in naive human embryonic stem cells. Proc Natl Acad Sci U S A, 113:E6382–E6390.
28.
KimH, WuJ, YeS, TaiC-I, ZhouX, YanH, LiP, PeraM and YingQ-L. (2013). Modulation of β-catenin function maintains mouse epiblast stem cell and human embryonic stem cell self-renewal. Nat Commun, 4:2403.
29.
BurdonT, StraceyC, ChambersI, NicholsJ and SmithA. (1999). Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev Biol, 210:30–43.
30.
TruslerO, HuangZ, GoodwinJ and LaslettAL. (2018). Cell surface markers for the identification and study of human naive pluripotent stem cells. Stem Cell Res, 26:36–43.
31.
ManorYS, MassarwaR and HannaJH. (2015). Establishing the human naive pluripotent state. Curr Opin Genet Dev, 34:35–45.
32.
GuoG, von MeyennF, SantosF, ChenY, ReikW, BertoneP, SmithA and NicholsJ. (2016). Naive pluripotent stem cells derived directly from isolated cells of the human inner cell mass. Stem Cell Reports, 6:437–446.
33.
WuJ, OkamuraD, LiM, SuzukiK, LuoC, MaL, HeY, LiZ, BennerC, et al. (2015). An alternative pluripotent state confers interspecies chimaeric competency. Nature, 521:316–321.
34.
SugimotoM, KondoM, KogaY, ShiuraH, IkedaR, HiroseM, OguraA, MurakamiA, YoshikiA, et al. (2015). A simple and robust method for establishing homogeneous mouse epiblast stem cell lines by WNT inhibition. Stem Cell Reports, 4:744–757.
35.
Van LanduytL, VerpoestW, VerheyenG, De VosA, Van de VeldeH, LiebaersI, DevroeyP and Van den AbbeelE. (2011). Closed blastocyst vitrification of biopsied embryos: evaluation of 100 consecutive warming cycles. Hum Reprod, 26:316–322.
36.
GardnerDK and SchoolcraftW. (1999). In vitro culture of human blastocysts. In: Toward Reproductive Certainty: Fertility and Genetics beyond 1999: The Plenary Proceedings of the 11th World Congress on In Vitro Fertilization and Human Reproductive Genetics, Parthenon, Pearl River, NY. JansenR and MortimerD, eds. Carnforth: Parthenon Publishing, pp 378–388.
37.
DuggalG, WarrierS, GhimireS, BroekaertD, Van der JeughtM, LiermanS, DerooT, PeelmanL, Van SoomA, et al. (2015). Alternative routes to induce naive pluripotency in human embryonic stem cells. Stem Cells, 33:2686–2698.
38.
Van der JeughtM, TaelmanJ, DuggalG, GhimireS, LiermanS, Chuva de Sousa LopesSM, DeforceD, DerooT, De SutterP and HeindryckxB. (2015). Application of small molecules favoring naive pluripotency during human embryonic stem cell derivation. Cell Reprogram, 17:170–180.
39.
GafniO, WeinbergerL, MansourAA, ManorYS, ChomskyE, Ben-YosefD, KalmaY, ViukovS, MazaI, et al. (2013). Derivation of novel human ground state naive pluripotent stem cells. Nature, 504:282–286.
40.
CostaM, DottoriM, NgE, HawesSM, SourrisK, JamshidiP, PeraMF, ElefantyAG and StanleyEG. (2005). The hESC line Envy expresses high levels of GFP in all differentiated progeny. Nat Methods, 2:259–260.
41.
DeleyeL, DheedeneA, De ConinckD, SanteT, ChristodoulouC, HeindryckxB, Van Den AbbeelE, De SutterP, DeforceD, MentenB and Van NieuwerburghF. (2015). Shallow whole genome sequencing is well suited for the detection of chromosomal aberrations in human blastocysts. Fertil Steril, 104:1276.e1–1285.e1.
42.
LiH. (2013). Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv preprint, arXiv:1303.3997.
43.
ScheininI, SieD, BengtssonH, van de WielMA, OlshenAB, van ThuijlHF, van EssenHF, EijkPP, RustenburgF, et al. (2014). DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly. Genome Res, 24:2022–2032.
44.
SanteT, VergultS, VoldersP-J, KloostermanWP, TrooskensG, De PreterK, DheedeneA, SpelemanF, De MeyerT and MentenB. (2014). ViVar: a comprehensive platform for the analysis and visualization of structural genomic variation. PLoS One, 9:e113800.
LoveMI, HuberW and AndersS. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol, 15:550.
47.
RobinsonMD, McCarthyDJ and SmythGK. (2010). edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics, 26:139–140.
48.
RobinsonMD, McCarthyDJ and SmythGK. (2010). EdgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics, 26.1:139–140.
49.
ZhangM, SchölerHR and GreberB. (2013). Rapid and efficient generation of neurons from human pluripotent stem cells in a multititre plate format. J Vis Exp, 73:e4335–e4335.
50.
LianX, ZhangJ, AzarinSM, ZhuK, HazeltineLB, BaoX, HsiaoC, KampTJ and PalecekSP. (2013). Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating WNT/β-catenin signaling under fully defined conditions. Nat Protoc, 8:162–175.
51.
KatsetosCD, LegidoA, PerentesE and MörkSJ. (2003). Class III β-Tubulin isotype: a key cytoskeletal protein at the crossroads of developmental neurobiology and tumor neuropathology. J Child Neurol, 18:851–866.
KelshRN. (2006). Sorting out SOX10 functions in neural crest development. BioEssays, 28:788–798.
54.
SunY, Nadal-VicensM, MisonoS, LinMZ, ZubiagaA, HuaX, FanG and GreenbergME. (2001). Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. Cell, 104:365–376.
55.
KaufmanDS, HansonET, LewisRL, AuerbachR and ThomsonJA. (2001). Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A, 98:10716–10721.
56.
XuC, InokumaMS, DenhamJ, GoldsK, KunduP, GoldJD and CarpenterMK. (2001). Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol, 19:971–974.
57.
CowanCA, KlimanskayaI, McMahonJ, AtienzaJ, WitmyerJ, ZuckerJP, WangS, MortonCC, McMahonAP, PowersD and MeltonDA. (2004). Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med, 350:1353–1356.
58.
EllerströmC, StrehlR, MoyaK, AnderssonK, BerghC, LundinK, HyllnerJ and SembH. (2006). Derivation of a xeno-free human embryonic stem cell line. Stem Cells, 24:2170–2176.
59.
PeuraT, BosmanA, ChamiO, JansenRPS, TexlovaK and StojanovT. (2008). Karyotypically normal and abnormal human embryonic stem cell lines derived from PGD-analyzed embryos. Cloning Stem Cells, 10:203–216.
60.
PeuraTT, SchaftJ and StojanovT. (2009). Derivation of human embryonic stem cell lines from vitrified human embryos. Methods Mol Biol, 584:21–54.
61.
BradleyCK, ScottHA, ChamiO, PeuraTT, DumevskaB, SchmidtU and StojanovT. (2011). Derivation of huntington's disease-affected human embryonic stem cell lines. Stem Cells Dev, 20:495–502.
62.
BradleyCK, SchaftJ, RoyTK, DumevskaB and PeuraTT. (2014). Derivation of human embryonic stem cell lines from vitrified human blastocysts. Methods Mol Biol, 1307:1–23.
63.
StephensonE, JacquetL, MiereC, WoodV, KadevaN, CornwellG, CodognottoS, DajaniY, BraudeP and IlicD. (2012). Derivation and propagation of human embryonic stem cell lines from frozen embryos in an animal product–free environment. Nat Protoc, 7:1366–1381.
64.
CrookJM, PeuraTT, KravetsL, BosmanAG, BuzzardJJ, HorneR, HentzeH, DunnNR, ZweigerdtR, et al. (2007). The generation of six clinical-grade human embryonic stem cell lines. Cell Stem Cell, 1:490–494.
65.
WangQ, FangZF, JinF, LuY, GaiH and ShengHZ. (2005). Derivation and growing human embryonic stem cells on feeders derived from themselves. Stem Cells, 23:1221–1227.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
